Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -2.23-10.800.5218.74-17.91

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is -2.23 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-2.23
Mar2023-10.80
Mar20220.52
Mar202118.74
Mar2020-17.91

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52
-97.23
Mar2021 18.74
Positive
Mar2020 -17.91 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,541.3 Cr 1.8% 3.4% -27% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,017.0 Cr 0.9% -0.1% 10.9% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 3.7% 3% 46.5% Stock Analytics
CIPLA ₹122,451.0 Cr 0.2% 2.8% 1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,620.0 Cr 7.3% 7.4% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,572.0 Cr -4% 2.6% 7.2% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

1.8%

3.4%

-27%

SENSEX

2%

2.8%

6.4%


You may also like the below Video Courses